title: A new dawn of anticoagulation for patients with antiphospholipid syndrome?
authors.forename: Ian
authors.initials: I
authors.lastname: Giles
authors.forename: Munther
authors.initials: M
authors.lastname: Khamashta
authors.forename: David
authors.initials: D
authors.lastname: D'Cruz
authors.forename: Hannah
authors.initials: H
authors.lastname: Cohen
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000503:physiopathology; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin